Bilcare Faces Financial Struggles Despite Strong Liquidity Position and Long-Term Resilience
Bilcare, a microcap in healthcare services, has faced significant financial challenges for the quarter ending September 2025, with a notable decline in key performance metrics. Despite achieving a high liquidity position, the company reported a substantial loss in profit after tax and low net sales, indicating operational difficulties.
Bilcare, a microcap player in the healthcare services sector, has recently undergone a financial trend adjustment reflecting a challenging performance for the quarter ending September 2025. The company's financial score has notably declined, indicating significant struggles in key performance metrics.On a positive note, Bilcare reported its highest cash and cash equivalents at Rs 45.97 crore, providing a solid liquidity position amidst the downturn. However, the company faced substantial challenges, with a reported profit after tax (PAT) of Rs -12.36 crore, marking a drastic decline compared to the previous four-quarter average. Additionally, net sales reached a low of Rs 178.20 crore, and operating profit to interest ratios fell to 0.18 times, further highlighting operational difficulties. The operating profit to net sales ratio was recorded at just 1.92%, and the profit before tax (PBT) less other income stood at Rs -27.87 crore, underscoring the financial strain.
In terms of market performance, Bilcare has shown resilience over the longer term, with impressive returns over one year, three years, and five years, significantly outpacing the Sensex. However, recent trends indicate a decline in stock performance over shorter periods, contrasting with the broader market's stability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
